Home
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: competition law
Wrapping up 2019 – Noteworthy Medicines Law and Policy Events
Ellen 't Hoen
-
December 30, 2019
Strong call for transparency on medicine prices, cost of R&D at...
Ellen 't Hoen
-
April 19, 2019
Humiragate: AbbVie’s desperate attempts to keep its monopoly
Ellen 't Hoen
-
March 27, 2019
Faced with unreasonable medicines prices, the Netherlands introduces pharmacy exemption in...
Ellen 't Hoen
-
February 22, 2019
Time to put a stop to the abuse of orphan drug...
Ellen 't Hoen
-
January 9, 2019
2018 Round-up of Noteworthy Medicines Law and Policy Events
Ellen 't Hoen
-
December 26, 2018
Dutch health insurance company Menzis takes AstraZeneca to court over patent...
Ellen 't Hoen
-
September 20, 2018
New Dutch Foundation to Address High Medicines Pricing Announces Plan to...
Ellen 't Hoen
-
August 25, 2018
The Italian Exception – A personalised approach to accessing high-priced patented...
Ellen 't Hoen
-
May 5, 2017
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
This work is licensed under Creative Commons.